International Congress of Parkinson’s Disease and Movement Disorders, Nice
September 22, 2019
Dr. Per Svenningsson will present the poster “A phase IIa trial studying the safety and tolerability of IRL752 in patients with Parkinson’s disease dementia” at the International Congress of Parkinson’s Disease and Movement Disorders held in Nice, France, during 22-26 September.
Website: https://www.mdscongress.org/Congress-2019.htm
